FDA — authorised 21 February 2001
- Application: NDA021265
- Marketing authorisation holder: SANDOZ CANADA INC
- Status: supplemented
FDA authorised vitamins on 21 February 2001 · 80,523 US adverse-event reports
Adverse reaction reports describe suspected side effects. A report does not mean the drug caused the event — co-medications, underlying disease and coincidence all contribute.
Yes. FDA authorised it on 21 February 2001; FDA has authorised it.
SANDOZ CANADA INC holds the US marketing authorisation.